Overcoming perceptions of financial barriers to rotavirus vaccine introduction in Asia

Human Vaccines and Immunotherapeutics

Volumn 9, Issue 11, 2013, Pages 2418-2426

  Nelson, E Anthony S ^a   De Quadros, Ciro A ^b   Santosham, Mathuram ^c   Parashar, Umesh D ^d   Steele, Duncan ^e  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b SABIN VACCINE INSTITUTE   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e BILL AND MELINDA GATES FOUNDATION   (United States)

Author keywords

Advisory committee; Evidence based decision making; Immunization financing; Immunization policy; National Immunization Technical Advisory Group; Policy recommendations; Rotavirus vaccine

Indexed keywords

NEW DRUG; ROTAVIRUS VACCINE;

ARTICLE; ASIA; CLINICAL DECISION MAKING; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG EFFICACY; DRUG SAFETY; ECONOMIC EVALUATION; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; LOWEST INCOME GROUP; POSTMARKETING SURVEILLANCE; ANIMAL; ECONOMICS; EPIDEMIOLOGY; FINANCIAL MANAGEMENT; HEALTH CARE COST; HEALTH CARE DELIVERY; ORGANIZATION AND MANAGEMENT; ROTAVIRUS INFECTIONS; UTILIZATION; VACCINATION;

ANIMALS; ASIA; CAPITAL FINANCING; HEALTH CARE COSTS; HEALTH SERVICES ACCESSIBILITY; HUMANS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; VACCINATION;

EID: 84887424461     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.26107     Document Type: Article

References (47)

1. Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, Dallas MJ, Heyse JF, Goveia MG, Black SB, et al.; Rotavirus Effcacy and Safety Trial (REST) Study Team. Safety and effcacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006; 354: 23-33; PMID: 16394299; http://dx.doi.org/10.1056/NEJMoa052664 (Pubitemid 43048948)
2. Ruiz-Palacios GM, Pérez-Schael I, Velá z quez FR, Abate H, Breuer T, Clemens SC, Cheuvart B, Espinoza F, Gillard P, Innis BL, et al.; Human Rotavirus Vaccine Study Group. Safety and effcacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006; 354: 11-22; PMID: 16394298; http://dx.doi.org/10.1056/NEJMoa052434 (Pubitemid 43048947)
3. World Health Organization. Rotavirus vaccines. Wkly Epidemiol Rec 2007; 82: 285-95; PMID: 17691162
4. World Health Organization. Rotavirus vaccination. Wkly Epidemiol Rec 2009; 84: 232-6
5. Buttery JP, Lambert SB, Grimwood K, Nissen MD, Field EJ, Macartney KK, Akikusa JD, Kelly JJ, Kirkwood CD. Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule. Pediatr Infect Dis J 2011; 30(Suppl):S25-9; PMID: 21183837; http://dx.doi.org/10.1097/INF.0b013e3181fefdee
6. Field EJ, Val ly H, Grimwood K, Lambert SB. Pentavalent rotavirus vaccine and prevention of gastroenteritis hospitalizations in Australia. Ped iat ric s 2010; 126:e506-12; PMID: 20732946; http://dx.doi.org/10.1542/peds.2010-0443
7. Paulke-Korinek M, Rendi-Wagner P, Kundi M, Kronik R, Kollaritsch H. Universal mass vaccination against rotavirus gastroenteritis: impact on hospitalization rates in austrian children. Pediatr Infect Dis J 2010; 29: 319-23; PMID: 199354 46
8. Hanquet G, Ducoffre G, Verg ison A, Neels P, Sabbe M, Va n Da m me P, Va n H e r c k K. Impact of rotavirus vaccination on laboratory confrmed cases in Belgium. Vaccine 2011; 29: 4698-703; PMID: 21571023; http://dx.doi.org/10.1016/ j.vaccine.2011.04.098
9. Raes M, Strens D, Vergison A, Verg hote M, Standaert B. Reduction in pediatric rotavirus-related hospitalizations after universal rotavirus vaccination in Belgium. Pediatr Infect Dis J 2011; 30:e120-5; PMID: 21436757; http://dx.doi.org/10.1097/INF.0b013e318214b811
10. Tate JE, Mutuc JD, Panozzo CA, Payne DC, Cortese MM, Cortes JE, Yen C, Esposito DH, Lopman BA, Patel MM, et al. Sustained decline in rotavirus detections in the United States following the introduction of rotavirus vaccine in 2006. Pediatr Infect Dis J 2011; 30(Suppl):S30-4; PMID: 21183838; http://dx.doi.org/10.1097/INF.0b013e3181ffe3eb
11. Gurgel RQ, Ilozue C, Correia JB, Centenari C, Oliveira SMT, Cuevas LE. Impact of rotavirus vaccination on diarrhoea mortality and hospital admissions in Brazil. Trop Med Int Health 2011; 16: 1180-4; PMID: 21749584; http://dx.doi. o r g/10.1111/j.13 65 - 315 6. 2 011.0 2 8 4 4. x
12. do Carmo GMI, Yen C, Cortes J, Siqueira AA, de Oliveira WK, Cortez-Escalante JJ, Lopman B, Flannery B, de Oliveira LH, Carmo EH, et al. Decline in diarrhea mortality and admissions after routine childhood rotavirus immunization in Brazil: a time-series analysis. PLoS Med 2011; 8:e1001024; PMID: 21526228; http://dx.doi.org/10.1371/journal. pmed.1001024
13. Yen C, Armero Guardado JA, Alberto P, Rodriguez Araujo DS, Mena C, Cuellar E, Nolasco JB, De Oliveira LH, Pastor D, Tate JE, et al. Decline in rotavirus hospitalizations and health care visits for childhood diarrhea following rotavirus vaccination in El Salvador. Pediatr Infect Dis J 2011; 30(Suppl):S6-10; PMID: 21048524; http://dx.doi.org/10.1097/INF.0b013e3181fefa05
14. de Palma O, Cruz L, Ramos H, de Baires A, Villatoro N, Pastor D, de Oliveira LH, Kerin T, Bowen M, Gentsch J, et al. Effectiveness of rotavirus vaccination against childhood diarrhoea in El Salvador: case-control study. BMJ 2010; 340:c2825; PMID: 20551120; http://dx.doi.org/10.1136/bmj. c2825
15. Quintanar-Solares M, Yen C, Richardson V, Esparza-Aguilar M, Parashar UD, Patel MM. Impact of rotavirus vaccination on diarrhea-related hospitalizations among children < 5 years of age in Mexico Pediatr Infect Dis J 2011 30 SUPPL. S11-5; PMID: 21183834; http://dx.doi.org/10.1097/INF.0b013e3181fefb32
16. Patel M, Pedreira C, De Oliveira LH, Tate J, Orozco M, Mercado J, Gonzalez A, Malespin O, Amador JJ, Umaña J, et al. Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua. JAMA 2009; 301: 2243-51; PMID: 19 49118 6; http://dx.doi.org/10.1001/ jama.2009.756
17. Molto Y, Cortes JE, De Oliveira LH, Mike A, Solis I, Suman O, Coronado L, Patel MM, Parashar UD, Cortese MM. Reduction of diarrhea-associated hospitalizations among children aged < 5 Years in Panama following the introduction of rotavirus vaccine. Pediatr Infect Dis J 2011; 30(Suppl): S16-20; PMID: 21183835; http://dx.doi.org/10.1097/INF.0b013e3181fefc68
18. Patel MM, Glass R, Desai R, Tate JE, Parashar UD. Fulflling the promise of rotavirus vaccines: how far have we come since licensure? Lancet Infect Dis 2012; 12: 561-70; PMID: 22742639; http://dx.doi.org/10.1016/S1473-3099(12)70029- 4
19. Macartney KK, Porwal M, Dalton D, Cripps T, Maldigri T, Isaacs D, Kesson A. Decline in rotavirus hospitalisations following introduction of Australia's national rotavirus immunisation programme. J Paediatr Child Health 2 011; 47: 266-70; PMID: 21244557; http://dx.doi. o r g/10.1111/j.14 4 0-175 4. 2 010.019 53. x
20. Lopman BA, Curns AT, Yen C, Parashar UD. Infant rotavirus vaccination may provide indirect protection to older children and adults in the United States. J Infect Dis 2011; 204: 980-6; PMID: 21878425; http://dx.doi.org/10.1093/infdis/ jir492
21. Richardson V, Hernandez-Pichardo J, Quintanar-Solares M, Esparza-Aguilar M, Johnson B, Gomez-Altamirano CM, Parashar U, Patel M. Effect of rotavirus vaccination on death from childhood diarrhea in Mexico. N Engl J Med 2010; 362: 299-305; PMID: 20107215; http://dx.doi.org/10.1056/NEJMoa0905211
22. World Health Organization. Rotavirus vaccines. WHO position paper - January 2013. Wkly Epidemiol Rec 2013; 88: 49-64; PMID: 23424730
23. McKinsey & Co. Mapping infuencers in the vaccine introduction decision-making process in developing countries. http://www.who.int/ immunization/stakeholders/mapping-vaccine-decision-making- networks.pdf (accessed 9 july 2013). 22-3-2007.
24. Makinen M, Kaddar M, Molldrem V, Wilson L. New vaccine adoption in lower-middle-income countries. Health Policy Plan 2012; 27(Suppl 2):ii39-49; PMID: 2 2513 731; http://dx.doi.org/10.1093/heapol/czs036
25. Nelson EA, Bresee JS, Parashar UD, Widdowson MA, Glass RI; Asian Rotavirus Surveillance Network. Rotavirus epidemiology: the Asian Rotavirus Surveillance Network. Vacci ne 2008; 26: 3192-6; PMID: 18485546; http://dx.doi.org/10.1016/j. vaccine.2008.03.073
26. Bresee JS, Hummelman E, Nelson EA, Glass RI. Rotavirus in Asia: the value of surveillance for informing decisions about the introduction of new vaccines. J Infect Dis 2005; 192 (Suppl 1):S1-5; PMID: 16088790; ht tp://dx.doi.or g/10.108 6/4 31515 (Pubitemid 41193095)
27. Nelson EA, Widdowson MA, Kilgore PE, Steele D, Parashar UD. A decade of the Asian Rotavirus Surveillance Network: achievements and future directions. Vaccine 2009; 27(Suppl 5):F1-3; PMID: 1993170 5; http://dx.doi.org/10.1016/j. vaccine.2009.09.001
28. Phua KB, Lim FS, Lau YL, Nelson EA, Huang LM, Quak SH, Lee BW, Te o h YL, Ta n g H, Boudville I, et al. Safety and effcacy of human rotavirus vaccine during the frst 2 years of life in Asian infants: randomised, double-blind, controlled study. Vacci ne 2009; 27: 5936-41; PMID: 19679216; http://dx.doi.org/10.1016/j.vaccine.2009.07.098
29. Phua KB, Lim FS, Lau YL, Nelson EA, Huang LM, Quak SH, Lee BW, van Doorn LJ, Te o h YL, Tang H, et al. Rotavirus vaccine RIX4414 effcacy sustained during the third year of life: a randomized clinical trial in an Asian population. Vaccine 2012; 30: 4552-7; PMID: 2 2 49 7 8 74; http://dx.doi.org/10.1016/j. vaccine.2012.03.030
30. Zaman K, Dang DA, Victor JC, Shin S, Yunus M, Dallas MJ, Podder G, Vu DT, Le TP, Luby SP, et al. Effcacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet 2010; 376: 615-23; PMID: 20692031; http://dx.doi.org/10.1016/S0140-6736(10)60755-6
31. Nelson EA, Sack D, Wolfson L, Wa lker DG, Seng LF, Steele D. Financing children's vaccines. Vaccine 2009; 27(Suppl 5):F12-7; PMID: 19931710; http://dx.doi.org/10.1016/j.vaccine.2009.08.072
32. Jit M, Edmunds WJ. Evaluating rotavirus vaccination in England and Wales. Part II. The potential cost-effectiveness of vaccination. Vaccine 2007; 25: 3971-9; PMID: 174 0 03 41; http://dx.doi.org/10.1016/j. vaccine.2007.02.070 (Pubitemid 46616994)
33. World Health Organization. Global Vaccine Action Plan. http://www.who.int/immunization/global- vaccine-action-plan/GVAP-doc-2011-2020/ en/index.html (accessed 1 May 2013).
34. Deogaonkar R, Hutubessy R, van der Putten I, Evers S, Jit M. Systematic review of studies evaluating the broader economic impact of vaccination in low and middle income countries. BMC Public Health 2012; 12: 878; PMID: 23072714; http://dx.doi.org/10.1186/1471-2458-12-878
35. Duclos P. Nationa l Immunization Technica l Advisory Groups (NITAGs): guidance for their establishment and strengthening. Vaccine 2010; 28(Suppl 1):A18-25; PMID: 20412991; http://dx.doi.org/10.1016/j. vaccine.2010.02.027
36. Gessner BD, Duclos P, Deroeck D, Nelson EA. Informing decision makers: experience and process of 15 National Immunization Technical Advisory Groups. Vacci ne 2010; 28(Suppl 1):A1-5; PMID: 20412988; http://dx.doi.org/10.1016/j. vaccine.2010.02.025
37. Nolan TM. The Australian model of immunization advice and vaccine funding. Vaccine 2010; 28(Suppl 1):A76-83; PMID: 20413003; http://dx.doi.org/10. 1016/j.vaccine.2010.02.038
38. Smith JC. The structure, role, and procedures of the U.S. Advisory Committee on Immunization Practices (ACIP). Vaccine 2010; 28(Suppl 1):A68-75; PMID: 20413002; http://dx.doi.org/10.1016/j. vaccine.2010.02.037
39. CDC. Advisory Committee on Immunization Practices (ACIP). http://www.cdc.gov/vaccines/acip/committee/charter.html (accessed 3 July 2013).
40. CDC. Vaccines for Children Program (VFC). http://www.cdc.gov/vaccines/ programs/vfc/awardees/vaccine-management/price-list/index.html (accessed 3 July 2013).
41. de Qadros CA, Carrasco P, Umstead W. EPI in the Americas Benefts for Revolving Fund. WHO Chron 1983; 37: 8185
42. DeRoeck D, Bawazir SA, Carrasco P, Kaddar M, Brooks A, Fitzsimmons J, Andrus J. Regional group purchasing of vaccines: review of the Pan American Health Organization EPI revolving fund and the Gulf Cooperation Council group purchasing program. Int J Health Plann Manage 2006; 21: 23-43; PMID: 16604847; http://dx.doi.org/10.1002/hpm.822
43. Freeman P. The PAHO Revolving Fund: History Operations and Contributions to Speeding Vaccine Introductions. An Information Paper for the Children's Vaccine Initiative. 1999.
44. PA HO. PAHO Revolving Fund. http://new.paho. org/hq/index.php?option=com- content&task=view &id=1864&Itemid=2234&lang=en (accessed 3 July 2013).
45. Stéphenne J. Vaccines as a global imperative - A business perspective. Health Aff (Millwood) 2011; 30: 1042-8; PMID: 21653955; http://dx.doi.org/10.1377/hlthaff.2011.0338
46. UNICEF. UNICEF presents its Middle Income Country New Vaccine Procurement Strategy to SAGE. http://www.unicef.org/supply/index-66348. html. (accessed 3 July 2013).
47. PATH. Page on Country Introductions of Rotavirus Vaccines. PATH Rotavirus Vaccine Access and Delivery Website. http://sites.path. org/rotavirusvaccine/ rotavirus-advocacy-and-communications-toolkit/country-introduction-maps-and- list/(accessed 11 July 2013).